Cases of paralytic poliomyelitis associated with oral antipoliomielytis vaccine in Cuba (1963-2006);Casos de poliomielitis paralítica asociada a la vacuna oral antipoliomielítica en Cuba (1963-2006)

Revista Cubana de Higiene y Epidemiologia

Volumn 46, Issue 2, 2008, Pages

  Más Lago, Pedro ^a   Ferrer, Helenio ^a   Goyenechea, Ángel ^a   Galindo, Ángel ^a   Sarmiento, Luis ^a   Fonseca, Magilé ^a   Morier, Luis ^a   Palomera, Rosa ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

Author keywords

Epidemic neuropathy; OPV; Poliomyelitis surveillance; Vaccine complications; VAPP

Indexed keywords

EID: 56749185542     PISSN: None     EISSN: 15613003     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Schonberger L, McGowan J, Gregg M. Vaccine-associated poliomyelitis in the United States 1961-1972. Am J Epidemiol. 1976;104:202-11.
2. Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis. 1992;14:568-79.
3. Wattigney WA, Mootrey GT, Braun MM, Chen RT. Surveillance for poliovirus vaccine adverse events 1991 to 1998: Impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Paediatrics. Disponible en: http//www.pediatrics.org/cgi/content/full/107/5/e83
4. Bottiger M. The elimination of polio in the Scandinavian countries. Public Health Reviews. 1993/94;21:27-34.
5. Joce R, Wood D, Brown D, Begg N. Paralytic poliomyelitis in England and Wales, 1985-91. British Med J. 1992;305:79-82.
6. de Oliver LH, Struchiner CJ. Vaccine-associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil. Int J Epidemiol. 2000;29:757-63.
7. Andrus JK, Strebel PM, de Quadros CA, Olive JM. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91. Bull World Health Organization. 1995;73:33-40.
8. Kohler KA, Banerjee K, Hlady WG, Andrus JK, Sutter RW. Vaccine-associated paralytic poliomyelitis in India during 1999: Decreased risk despite massive use or oral polio vaccine. Bull World Health Organization. 2002;80:210-6.
9. Kohler KA, Banerjee K, Sutter RW. Further clarity on vaccine-associated paralytic polio in India. Bull World Health Organization. 2002;80:987.
10. del Puerto CQ, Ferrer HG, Toledo GC. Higiene y Epidemiología. Apuntes para la historia. Editorial. La Habana, Cuba: Palacio de las Convenciones; 2002. p. 186-8.
11. World Health Assembly. Global eradication of poliomyelitis by the year 2000. Geneva: World Health Organization; 1988. Resolution WHA 41.28
12. Más Lago P. Eradication of poliomyelitis in Cuba: a historical perspective. Bulletin World Health Organization. 1999;77:681-7.
13. Teja JP, Ramírez AM, Córdova LV, Santín MP, Galindo MA, Más Lago P. Informe preliminar del Ministerio de Salud Pública de Cuba para optar por el "Certificado de erradicación de la poliomielitis" en el continente Americano. Editora: Liliana Jiménez. Ciudad de La Habana: MINSAP; 1994.
14. Más Lago P, Cáceres VM, Galindo MA, Gary HE Jr, Valcarcel M, Barrios J, Sarmiento L, Ávalos I, et al. Persistence of vaccine-drived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol. 2001;30:1029-34.
15. Más Lago P, Gary HE Jr, Sarmiento LP, Cáceres VM, Barrios J, Palomera RP, Bello MC, et al. Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba. Int J Epidemiol. 2003;32:772-7.
16. Manual for the Virological Investigation of polio. WHO/EPI/GEN/97.01
17. Gay J, Porrata C, Hernández M, Argüelles JA, Cabrera A. Correspondence to the Editors. Bulletin PAHO. 1996;30:87-8.
18. Jiménez S, Porrata C, Rodríguez A, Cabrera A, Gay J. Estudios alimentariosnutricionales. Taller Internacional sobre Neuropatía Epidémica ocurrida en Cuba. Habana, 12-15 Julio 1994.
19. Grupo Operativo Nacional. Neuropatía Epidémica en Cuba. La Habana: Centro Nacional de Información de Ciencias Médicas; 1993.
20. Cuba, Ministerio de Salud Pública. Plan Nacional de Salud Pública. La Habana, Cuba: MINSAP; 1994.
21. Más Lago P, Pelegrino JL, Guzmán MG, Comellas MM, Resik S, Álvarez M, et al. Viral isolation from cases of Epidemic Neuropathy in Cuba. Arch Path Lab Med. 1997;121:825-33.
22. Cuba Neuropathy Field Investigation Team. Epidemic Optic Neuropathy in Cuba-Clinical characterization and risk factor. New Engl J Med. 1995;333:1176-82.
23. Gay J, Porrata C, Hernández M, Clua AM, Arguelles JM. Dietary factors in Epidemic Neuropathy on the Isle Youth, Cuba. Bull Pan Health Org. 1995:29:25.
24. Caggana M, Chan P, Ramsingh A. Identification of a single amino acid residue in the capsid protein VP1 of Coxsackie B4 that determine the virulent phenotype. J Virol. 1993;67:4797-803.
25. Colbere-Garapin F, Chiristodoulov C, Crainic R, Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci USA. 1989;86:7590-94.
26. Beck MA, Levander OA. Dietary oxidative stress and the potentiation of viral infection. Annu Rev Nutr. 1998;18:93-116.
27. Broome CS, McArdle F, Kyle JAM, Andrews F, Lowe NM, Hart CA, et al. An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am J Clin Nutr. 2004;80:154-62.
28. Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, et al. Circulating vaccine-derived poliovirus: current state of knowledge. Bull World Health Organization. 2004;82:16-21.
29. MINSAP, CNT, CIGB, CN, CENIC, otros centros. Epidemic neuropathy-Cuba, 1991-1994. JAMA. 1994;271:1154-6.
30. Kuntz D. The politics of suffering: the impact of the U.S. embargo on the health of the Cuban people. Inter J Health Services. 1994;24:161-79.
31. Más Lago P, Bravo JR, Andrus JK, Comellas MM, Galindo MA, de Quadros CA, et al. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies. Bull World Health Organization. 1994;72:221-5.